South & Central America Embolotherapy Market

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028

Analysis By Product (Embolic Agent and Support Device), Disease Indication (Cancer, Peripheral Vascular Disease, Neurological Disease, Urological and Nephrological Disorder, Gastrointestinal Disorder, and Other), Procedure [Transcatheter Arterial Embolization (TAE), Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT), and Transarterial Chemoembolization (TACE)], and End User (Hospital & Clinic, Ambulatory Surgery Center, and Other End User)

No. of Pages: 163
Report Code: BMIRE00027552
Category: Life Sciences
South & Central America Embolotherapy Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. South & Central America Embolotherapy Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. South & Central America Embolotherapy Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. South & Central America Embolotherapy Market Regional Analysis

6.2 South & Central America Embolotherapy Market Revenue 2020-2028 (US$ Million)
6.3 South & Central America Embolotherapy Market Forecast Analysis

7. South & Central America Embolotherapy Market Analysis – by Product

7.1 Embolic Agent
  • 7.1.1 Overview
  • 7.1.2 Embolic Agent: South & Central America Embolotherapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.2 Support Device
  • 7.2.1 Overview
  • 7.2.2 Support Device: South & Central America Embolotherapy Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. South & Central America Embolotherapy Market Analysis – by Disease Indication

8.1 Cancer
  • 8.1.1 Overview
  • 8.1.2 Cancer: South & Central America Embolotherapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.2 Peripheral Vascular Disease
  • 8.2.1 Overview
  • 8.2.2 Peripheral Vascular Disease: South & Central America Embolotherapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.3 Neurological Disease
  • 8.3.1 Overview
  • 8.3.2 Neurological Disease: South & Central America Embolotherapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.4 Urological and Nephrological Disorder
  • 8.4.1 Overview
  • 8.4.2 Urological and Nephrological Disorder: South & Central America Embolotherapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.5 Gastrointestinal Disorder
  • 8.5.1 Overview
  • 8.5.2 Gastrointestinal Disorder: South & Central America Embolotherapy Market – Revenue and Forecast, 2020-2028 (US$ Million)

9. South & Central America Embolotherapy Market Analysis – by Procedure

9.1 Transcatheter Arterial Embolization
  • 9.1.1 Overview
  • 9.1.2 Transcatheter Arterial Embolization: South & Central America Embolotherapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.2 Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
  • 9.2.1 Overview
  • 9.2.2 Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy: South & Central America Embolotherapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.3 Transarterial Chemoembolization
  • 9.3.1 Overview
  • 9.3.2 Transarterial Chemoembolization: South & Central America Embolotherapy Market – Revenue and Forecast, 2020-2028 (US$ Million)

10. South & Central America Embolotherapy Market Analysis – by End User

10.1 Hospital & Clinic
  • 10.1.1 Overview
  • 10.1.2 Hospital & Clinic: South & Central America Embolotherapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
10.2 Ambulatory Surgery Center
  • 10.2.1 Overview
  • 10.2.2 Ambulatory Surgery Center : South & Central America Embolotherapy Market – Revenue and Forecast, 2020-2028 (US$ Million)

11. South & Central America Embolotherapy Market – South and Central America Analysis

11.1 Overview

11.2 South and Central America
  • 11.2.1 South & Central America Embolotherapy Market Breakdown, by Key Country, 2023 and 2028 (%)
  • 11.2.1.1 South & Central America Embolotherapy Market – Revenue and Forecast Analysis – by Country
  • 11.2.1.1 Brazil: South & Central America Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
    • 11.2.1.1.1 Brazil: South & Central America Embolotherapy Market Breakdown, by Product
    • 11.2.1.1.2 Brazil: South & Central America Embolotherapy Market Breakdown, by Disease Indication
    • 11.2.1.1.3 Brazil: South & Central America Embolotherapy Market Breakdown, by Procedure
    • 11.2.1.1.4 Brazil: South & Central America Embolotherapy Market Breakdown, by End User
  • 11.2.1.2 Argentina: South & Central America Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
    • 11.2.1.2.1 Argentina: South & Central America Embolotherapy Market Breakdown, by Product
    • 11.2.1.2.2 Argentina: South & Central America Embolotherapy Market Breakdown, by Disease Indication
    • 11.2.1.2.3 Argentina: South & Central America Embolotherapy Market Breakdown, by Procedure
    • 11.2.1.2.4 Argentina: South & Central America Embolotherapy Market Breakdown, by End User
  • 11.2.1.3 Rest of South and Central America : South & Central America Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
    • 11.2.1.3.1 Rest of South and Central America : South & Central America Embolotherapy Market Breakdown, by Product
    • 11.2.1.3.2 Rest of South and Central America : South & Central America Embolotherapy Market Breakdown, by Disease Indication
    • 11.2.1.3.3 Rest of South and Central America : South & Central America Embolotherapy Market Breakdown, by Procedure
    • 11.2.1.3.4 Rest of South and Central America : South & Central America Embolotherapy Market Breakdown, by End User

12. Competitive Landscape

12.1 Heat Map Analysis
12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments

14. Company Profiles

14.1 Abbott Laboratories
  • 14.1.1 Key Facts
  • 14.1.2 Business Description
  • 14.1.3 Products and Services
  • 14.1.4 Financial Overview
  • 14.1.5 SWOT Analysis
  • 14.1.6 Key Developments
14.2 Boston Scientific Corporation
  • 14.2.1 Key Facts
  • 14.2.2 Business Description
  • 14.2.3 Products and Services
  • 14.2.4 Financial Overview
  • 14.2.5 SWOT Analysis
  • 14.2.6 Key Developments
14.3 Cook Medical LLC
  • 14.3.1 Key Facts
  • 14.3.2 Business Description
  • 14.3.3 Products and Services
  • 14.3.4 Financial Overview
  • 14.3.5 SWOT Analysis
  • 14.3.6 Key Developments
14.4 Johnson & Johnson
  • 14.4.1 Key Facts
  • 14.4.2 Business Description
  • 14.4.3 Products and Services
  • 14.4.4 Financial Overview
  • 14.4.5 SWOT Analysis
  • 14.4.6 Key Developments
14.5 Medtronic
  • 14.5.1 Key Facts
  • 14.5.2 Business Description
  • 14.5.3 Products and Services
  • 14.5.4 Financial Overview
  • 14.5.5 SWOT Analysis
  • 14.5.6 Key Developments
14.6 Acandis GmbH
  • 14.6.1 Key Facts
  • 14.6.2 Business Description
  • 14.6.3 Products and Services
  • 14.6.4 Financial Overview
  • 14.6.5 SWOT Analysis
  • 14.6.6 Key Developments
14.7 Balt USA LLC
  • 14.7.1 Key Facts
  • 14.7.2 Business Description
  • 14.7.3 Products and Services
  • 14.7.4 Financial Overview
  • 14.7.5 SWOT Analysis
  • 14.7.6 Key Developments
14.8 Stryker Corporation
  • 14.8.1 Key Facts
  • 14.8.2 Business Description
  • 14.8.3 Products and Services
  • 14.8.4 Financial Overview
  • 14.8.5 SWOT Analysis
  • 14.8.6 Key Developments
14.9 Guerbet LLC
  • 14.9.1 Key Facts
  • 14.9.2 Business Description
  • 14.9.3 Products and Services
  • 14.9.4 Financial Overview
  • 14.9.5 SWOT Analysis
  • 14.9.6 Key Developments
14.10 Terumo Corporation
  • 14.10.1 Key Facts
  • 14.10.2 Business Description
  • 14.10.3 Products and Services
  • 14.10.4 Financial Overview
  • 14.10.5 SWOT Analysis
  • 14.10.6 Key Developments

15. Appendix

15.1 About Business Market Insights
15.2 List of Abbreviations

The List of Companies - South & Central America Embolotherapy Market

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Cook Medical LLC
  • Johnson & Johnson
  • Medtronic
  • Acandis GmbH
  • Balt USA LLC
  • Stryker Corporation
  • Guerbet LLC
  • Terumo Corporation
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)